Wilson Sonsini Goodrich & Rosati advised Doron Therapeutics on the transaction. Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, announced it has raised...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Harbour on the transaction. Imperial Dade, a leading North American distributor of foodservice packaging supplies, industrial products, and janitorial supplies,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Nature’s Toolbox on the transaction. Nature’s Toolbox (NTx) announced the close of a $47.5 million Series B funding round led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ambient Photonics on the transaction. Ambient Photonics has secured $30 million in a Series A2 funding round. The round was led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Fastcase on the transaction. Legal technology companies vLex and Fastcase announced that they are merging. Oakley Capital and Bain Capital Credit agreed to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cognito on the transaction. Neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Elucidata on the transaction. TechBio company Elucidata announced that it has raised $16 million in a Series A fundraising, which...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Investor Time BioVentures on the deal while WilmerHale represented Phantom Neuro. Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised ArrePath on the deal. ArrePath, an anti-infective drug discovery company addressing drug resistant infections, announced it has raised $20 million in seed financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneer in the development of precision-based gastrointestinal (GI) disease technologies and software,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneering company aiming to bring cutting-edge precision medicine to gastroenterology, closed a...
You must be a Standard 1 Year member to access this content.
